Burrows Francis 4

What Happened

• Francis Burrows, Chief Scientific Officer of Kura Oncology, sold 1,311 shares of KURA stock in an open-market transaction on January 27, 2026. The shares were sold at $8.46 each for a total of approximately $11,092. The filing notes this was a sell-to-cover to satisfy taxes on vested RSUs.

Key Details

• Transaction date and price: 2026-01-27, 1,311 shares sold at $8.46 per share.
• Total proceeds: ~$11,092.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: Sell-to-cover for taxes associated with the vesting of an RSU received by the reporting person dated 01/26/2022.
• Filing date: Form 4 filed 2026-01-27 (same day as the reported transaction); no late-filing indication in the provided record.
• Transaction type code: S = Sale; footnote indicates tax withholding (sell-to-cover).

Context

• Sell-to-cover transactions are routine: companies or insiders often sell a small number of shares to cover withholding taxes when restricted stock units vest. Such sales are administrative and do not necessarily indicate a change in the insider’s view of the company.
• The size of this transaction is small relative to typical insider trades and should be interpreted as tax-related rather than a market signal.